232 related articles for article (PubMed ID: 10262071)
1. Dispensing controlled substances in institutional practitioner emergency rooms--Drug Enforcement Administration. Notice of proposed rulemaking.
Fed Regist; 1982 Sep; 47(181):41140. PubMed ID: 10262071
[TBL] [Abstract][Full Text] [Related]
2. Prescriptions; dispensing controlled substances in institutional practitioner emergency rooms--Drug Enforcement Administration, Justice. Withdrawal of proposed rule.
Fed Regist; 1983 Jun; 48(125):29713-4. PubMed ID: 10261481
[TBL] [Abstract][Full Text] [Related]
3. Changes to patient limitation for dispensing or prescribing approved narcotic controlled substances for maintenance or detoxification treatment by qualified individual practitioners. Final rule.
Drug Enforcement Administration (DEA), Justice
Fed Regist; 2008 May; 73(100):29685-8. PubMed ID: 18605404
[TBL] [Abstract][Full Text] [Related]
4. Prescriptions for Schedule II controlled substances: Drug Enforcement Administration, Justice. Notice of proposed rulemaking.
Fed Regist; 1980 Apr; 45(70):24199-200. PubMed ID: 10246081
[TBL] [Abstract][Full Text] [Related]
5. DEA issues proposed rule on e-prescribing.
Ball FR
J Med Pract Manage; 2009; 24(4):243. PubMed ID: 19288650
[TBL] [Abstract][Full Text] [Related]
6. Issuance of multiple prescriptions for schedule II controlled substances. Final rule.
Drug Enforcement Administration (DEA), Department of Justice
Fed Regist; 2007 Nov; 72(222):64921-30. PubMed ID: 18038486
[TBL] [Abstract][Full Text] [Related]
7. The regulatory process: impacting the NP's role.
Wysocki S
Nurse Pract Forum; 1992 Jun; 3(2):56-7. PubMed ID: 1392671
[TBL] [Abstract][Full Text] [Related]
8. Drug Enforcement Administration--controlled substances in emergency kits for long term care facilities. Statement of policy.
Fed Regist; 1980 Apr; 45(70):24128. PubMed ID: 10246080
[TBL] [Abstract][Full Text] [Related]
9. Prescriptions; requirements clarification--Drug Enforcement Administration (DEA). Final rule.
Fed Regist; 1991 Jun; 56(106):25025-7. PubMed ID: 10111144
[TBL] [Abstract][Full Text] [Related]
10. Dispensing of controlled substances to assist suicide. Interpretive rule.
Department of Justice
Fed Regist; 2001 Nov; 66(218):56607-8. PubMed ID: 11760766
[TBL] [Abstract][Full Text] [Related]
11. Baby doe redux? The Department of Health and Human Services and the Born-Alive Infants Protection Act of 2002: a cautionary note on normative neonatal practice.
Sayeed SA
Pediatrics; 2005 Oct; 116(4):e576-85. PubMed ID: 16199687
[TBL] [Abstract][Full Text] [Related]
12. Allowing central fill pharmacies and retail pharmacies to fill prescriptions for controlled substances on behalf of retail pharmacies. Final rule.
Drug Enforcement Administration (DEA), Justice
Fed Regist; 2003 Jun; 68(121):37405-11. PubMed ID: 12836645
[TBL] [Abstract][Full Text] [Related]
13. The federal Drug Enforcement Administration "prescription series" proposal: continuing concerns.
Gilson AM; Joranson DE
J Pain Palliat Care Pharmacother; 2007; 21(4):21-4. PubMed ID: 18032312
[TBL] [Abstract][Full Text] [Related]
14. Authority for practitioners to dispense or prescribe approved narcotic controlled substances for maintenance or detoxification treatment. Final rule.
Drug Enforcement Administration (DEA), Justice
Fed Regist; 2005 Jun; 70(120):36338-44. PubMed ID: 15973789
[TBL] [Abstract][Full Text] [Related]
15. Controlled substances in long-term care pharmacy: part 2.
Martin CM
Consult Pharm; 2008 Oct; 23(10):742-56. PubMed ID: 19032014
[TBL] [Abstract][Full Text] [Related]
16. New Drug Enforcement Administration guideline for communicating controlled substance prescriptions to pharmacies.
Drug Enforcement Adminstration U S Department of Justice
J Pain Palliat Care Pharmacother; 2011; 25(1):83-9. PubMed ID: 21426229
[TBL] [Abstract][Full Text] [Related]
17. Definition of "positional isomer" as it pertains to the control of schedule I controlled substances. Final rule.
Drug Enforcement Administration (DEA), Department of Justice
Fed Regist; 2007 Dec; 72(231):67850-2. PubMed ID: 18064769
[TBL] [Abstract][Full Text] [Related]
18. Exempt chemical mixtures containing gamma-butyrolactone. Final rule.
Drug Enforcement Administration (DEA), Justice
Fed Regist; 2010 Jun; 75(124):37301-7. PubMed ID: 20608286
[TBL] [Abstract][Full Text] [Related]
19. Exemption of chemical mixtures containing the List I chemicals ephedrine, N-methylephedrine, N-methylpseudoephedrine, norpseudoephedrine, phenylpropanolamine, and pseudoephedrine. Final rule.
Drug Enforcement Administration (DEA), Justice
Fed Regist; 2003 May; 68(84):23195-206. PubMed ID: 12725239
[TBL] [Abstract][Full Text] [Related]
20. Clarification of registration requirements for individual practitioners. Final rule.
Drug Enforcement Administration (DEA), Department of Justice
Fed Regist; 2006 Dec; 71(231):69478-80. PubMed ID: 17171847
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
